199.92 USD
+0.18 (+0.09%)
199.95 USD
+0.03 (+0.02%)
ChartMill assigns a Buy % Consensus number of 72% to RXDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 198.9. This target is -0.51% below the current price.
RXDX was analyzed by 15 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about RXDX.
In the previous month the buy percentage consensus was at a similar level.
RXDX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-10 | RBC Capital | Maintains | Sector Perform |
| 2023-05-10 | Jefferies | Downgrade | Buy -> Hold |
| 2023-04-18 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-04-18 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-04-18 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-04-18 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-04-17 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-04-17 | Stifel | Downgrade | Buy -> Hold |
| 2023-03-06 | Guggenheim | Maintains | Buy |
| 2023-03-01 | Oppenheimer | Maintains | Outperform |
| 2023-03-01 | Credit Suisse | Maintains | Outperform |
| 2023-01-31 | Goldman Sachs | Maintains | Buy |
| 2022-12-08 | BTIG | Maintains | Buy |
| 2022-12-08 | Oppenheimer | Maintains | Outperform |
| 2022-12-08 | RBC Capital | Maintains | Outperform |
| 2022-12-08 | Credit Suisse | Maintains | Outperform |
| 2022-11-01 | Stifel | Maintains | Buy |
| 2022-10-04 | Oppenheimer | Maintains | Outperform |
| 2022-10-04 | RBC Capital | Maintains | Outperform |
| 2022-10-03 | BTIG | Maintains | Buy |
| 2022-08-29 | Wells Fargo | Maintains | Overweight |
| 2022-08-29 | Piper Sandler | Maintains | Overweight |
| 2022-08-12 | SVB Leerink | Maintains | Outperform |
| 2022-08-12 | Credit Suisse | Maintains | Outperform |
| 2022-07-20 | Goldman Sachs | Initiate | Buy |
| 2022-06-10 | Piper Sandler | Initiate | Overweight |
| 2022-05-13 | RBC Capital | Maintains | Outperform |
| 2022-05-13 | Wells Fargo | Maintains | Overweight |
| 2022-03-10 | SVB Leerink | Maintains | Outperform |
| 2022-03-10 | Wells Fargo | Maintains | Overweight |
PROMETHEUS BIOSCIENCES INC / RXDX FAQ
What do analysts expect the price target to be for PROMETHEUS BIOSCIENCES INC (RXDX)?
15 analysts have analysed RXDX and the average price target is 198.9 USD. This implies a price decrease of -0.51% is expected in the next year compared to the current price of 199.92.
What is the consensus rating for PROMETHEUS BIOSCIENCES INC (RXDX) stock?
The consensus rating for PROMETHEUS BIOSCIENCES INC (RXDX) is 72 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover PROMETHEUS BIOSCIENCES INC (RXDX) stock?
The number of analysts covering PROMETHEUS BIOSCIENCES INC (RXDX) is 15.